AbbVie (ABBV.US) has reached an acquisition agreement to expand its presence in the field of autoimmune diseases.
AbbVie (ABBV.US) announced that it has reached a final agreement with Nimble Therapeutics.
AbbVie Announces Leadership Change With New Appointment
Weekly Buzz: Tech stocks hit high scores on ominous day
AbbVie: David R. Purdue Will Be Senior Vice President, Controller
AbbVie: Kevin K. Buckbee, Senior Vice President, Controller, Plans to Retire From Controller Role Effective March 1
This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025?
